Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00913159 · ClinicalTrials.gov registry record · NA
A Trial Comparing Efficacy of HM3 Versus F2 Lithotripters for Stone Fragmentation
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT00913159 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 5 participants.
The verdict
NCT00913159, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The older lithotripter, HM3, has over 90% stone-free rate in most studies. However, it's less transportable than the new model, F2. There are no prospective trials performed to make a valid comparison between these 2 lithotripters in terms of efficacy of stone fragmentation and clinical outcomes.
Interventions
- PROCEDURE Extracorporeal Shock Wave Lithotripsy (ESWL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00913159
The ClinicalTrials.gov registry entry for NCT00913159 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Extracorporeal Shock Wave Lithotripsy (ESWL) is the first listed.
NCT00913159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00913159 about?
NCT00913159 is a clinical study titled "A Trial Comparing Efficacy of HM3 Versus F2 Lithotripters for Stone Fragmentation". The older lithotripter, HM3, has over 90% stone-free rate in most studies. However, it's less transportable than the new model, F2. There are no prospective trials performed to make a valid comparison between these 2 lithotripters in terms of efficacy of stone fragmentation and clinical outcomes.
What is the current status of trial NCT00913159?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2009-11. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00913159?
The interventions under investigation include: Extracorporeal Shock Wave Lithotripsy (ESWL) (PROCEDURE).
Who is sponsoring clinical trial NCT00913159?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.